Nurse Practitioner, Family · Chula Vista, CA
NPI
1972956514
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
251 Landis Ave
Chula Vista, CA, 91910
Phone (619) 515-2500
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$571K
4,766 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Adriana G Celiz prescribed most often to Medicare patients was Atorvastatin Calcium, with 315 prescriptions and refills. In total Adriana G Celiz wrote 4,766 Medicare prescriptions that cost $571K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 315 | 316 | 47 | $16K |
| Gabapentin Generic | 196 | 197 | 24 | $5,980 |
| Amlodipine Besylate Generic | 191 | 194 | 28 | $4,693 |
| Pantoprazole Sodium Generic | 162 | 162 | 25 | $9,179 |
| Omeprazole Generic | 139 | 140 | 22 | $7,210 |
| Metformin Hcl Generic | 131 | 131 | 16 | $2,153 |
| Levothyroxine Sodium Generic | 129 | 130 | 17 | $1,756 |
| Escitalopram Oxalate Generic | 117 | 117 | 16 | $5,353 |
| Furosemide Generic | 111 | 111 | 16 | $1,253 |
| Losartan Potassium Generic | 105 | 110 | 19 | $3,202 |
| Ozempic Semaglutide | 97 | 104 | 14 | $98K |
| Carvedilol Generic | 85 | 85 | 13 | $3,784 |
| Metformin Hcl Er Metformin Hcl | 85 | 85 | 11 | $2,018 |
| Memantine Hcl Generic | 84 | 84 | 12 | $6,287 |
| Valsartan Generic | 76 | 77 | 12 | $3,744 |
Brand drugs: 782 claims; generic drugs: 3,908 claims; opioid claims: 32.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Adriana G Celiz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.